Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) and ENDRA Life Sciences (NASDAQ:NDRA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations.
Insider and Institutional Ownership
83.4% of Tactile Systems Technology shares are held by institutional investors. Comparatively, 1.2% of ENDRA Life Sciences shares are held by institutional investors. 2.1% of Tactile Systems Technology shares are held by company insiders. Comparatively, 10.0% of ENDRA Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Valuation & Earnings
This table compares Tactile Systems Technology and ENDRA Life Sciences”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Tactile Systems Technology | $329.52 million | 2.07 | $19.09 million | $0.88 | 34.41 |
| ENDRA Life Sciences | N/A | N/A | -$7.03 million | ($8.15) | -0.61 |
Tactile Systems Technology has higher revenue and earnings than ENDRA Life Sciences. ENDRA Life Sciences is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of current ratings for Tactile Systems Technology and ENDRA Life Sciences, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Tactile Systems Technology | 0 | 2 | 4 | 1 | 2.86 |
| ENDRA Life Sciences | 1 | 0 | 1 | 0 | 2.00 |
Tactile Systems Technology presently has a consensus target price of $38.60, suggesting a potential upside of 27.48%. ENDRA Life Sciences has a consensus target price of $25.00, suggesting a potential upside of 401.00%. Given ENDRA Life Sciences’ higher probable upside, analysts plainly believe ENDRA Life Sciences is more favorable than Tactile Systems Technology.
Profitability
This table compares Tactile Systems Technology and ENDRA Life Sciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Tactile Systems Technology | 5.91% | 9.70% | 7.53% |
| ENDRA Life Sciences | N/A | -433.64% | -204.58% |
Risk & Volatility
Tactile Systems Technology has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500. Comparatively, ENDRA Life Sciences has a beta of -0.04, suggesting that its stock price is 104% less volatile than the S&P 500.
Summary
Tactile Systems Technology beats ENDRA Life Sciences on 12 of the 14 factors compared between the two stocks.
About Tactile Systems Technology
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
About ENDRA Life Sciences
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.
